[#DIV28SUPER] Fw: Register Today! Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws - A Workshop

Hello colleagues,

Please see below a webinar focused on methadone prescribing practices, with a hopeful emphasis on expanding access to methadone.

Warm regards,

Kelly

---
Kelly Dunn, Ph.D., M.B.A.

Associate Professor
Behavioral Pharmacology Research Unit
Department of Psychiatry and Behavioral Sciences
Johns Hopkins School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
P:410-550-2254; F:410-550-0030

---

View this email in your browser   Register Today!    Methadone Treatment for Opioid Use Disorder: Examining Federal Regulations and Laws: A Workshop March 3, 2022 | 9:30am-5:00pm ET March 4, 2022 | 9:30am-4:30pm ET   Opioid use disorder (OUD)—a chronic brain disease caused by prolonged use of prescription opioids, heroin, or other illicit opioids—imposes heavy costs on individuals, their families, and society. Methadone is one of three safe and highly effective medications that are approved by the U.S. Food and Drug Administration to treat OUD; however, stringent laws and regulatory policies pose substantial barriers to provision of and access to quality treatment.  On March 3-4, 2022, the National Academies of Sciences, Engineering, and Medicine'sBoard on Health Sciences Policy and Board on Health Care Services, and National Academy of Medicine's Action Collaborative on Countering the U.S. Opioid Epidemic will host a public workshop bringing together experts and key stakeholders to examine the current federal regulatory and legal landscape regarding provision of and access to methadone for the treatment of opioid use disorder.  Invited presentations and discussions will be designed to: Examine current federal regulations governing methadone treatment services, including the current COVID-19 emergency regulatory relief;  Discuss the impact of these regulations relative to other factors affecting treatment services;  Explore potential options for modifying federal regulations and laws to expand access to quality treatment with methadone; and Explore state laws that may conflict with federal regulations.  This workshop is sponsored by the Office of National Drug Control Policy, Executive Office of the President. For more information, including the planning committee slate and biographies, please visitour website.   Register Now

--

Kelly Dunn, Ph.D., MBA

Associate Professor

Behavioral Pharmacology Research Unit

Department of Psychiatry and Behavioral Science
Johns Hopkins University School of Medicine
5510 Nathan Shock Drive
Baltimore, MD 21224
BPRU Phone: (410) 550-2254
Fax: (410) 550-0030
 
WARNING:  E-mail sent over the Internet is not secure.  Information sent by e-mail may not remain confidential.
DISCLAIMER:  This e-mail is intended only for the individual to whom it is addressed.  It may be used only in accordance with applicable laws.  If you received this e-mail by mistake, notify the sender and destroy the e-mail